Elevated leptin levels in healthy climacteric women from Northeastern Brazil: an effect of age or adiposity?

• Published in: Archives of Endocrinology and Metabolism Vol. 64; no. 3; pp. 276 - 281
• Main Authors: Maniçoba, Ana Cyntia B. N., Oliveira, Clariano P., Nascimento, Johnny. R., Nascimento, Flávia R. F., Brito, Haissa O., Costa, Rui Miguel Gil da, Barbosa, Maria do Carmo L., Faria, Manuel dos Santos, Nascimento, Maria do Desterro S. B., Brito, Luciane M. O.
• Format: Journal Article
• Language: English
• Published: Sociedade Brasileira de Endocrinologia e Metabologia 01.05.2020; Brazilian Society of Endocrinology and Metabolism
• Subjects: climacterium; inflammation; leptin; Metabolic syndrome, menopause; Original
• ISSN: 2359-3997; 2359-4292
• DOI: 10.20945/2359-3997000000249

ABSTRACT Objective Climacterium is associated with elevated leptin levels and increased risk of cardiovascular disorders. Conflicting data diverge on whether high leptin levels in climacterium reflect increasing adipose mass or, at least partially, age-related hormonal changes. This study addresses this issue in women from a Brazilian state with a low human development index. Subjects and methods A case-control study was conducted, enrolling 136 women from the state of Maranhão, 52 (38.2%) climacteric and 84 (61.8%) non-climacteric. Biometric, biochemical, hormonal and immunological parameters were analyzed. Results Climacteric women showed a moderately increased waist/hip ratio (0.894 versus 0.834, p < 0.05), sustained body mass index (27.46 versus 28.68, p > 0.05) increased leptin levels (9.59 versus 7.13, p < 0.05) and no evidence of metabolic syndrome. No other parameters were altered. The climacteric cohort didn’t show significant body fat gains but displayed a typical age-related redistribution of adipose tissue. Even so, leptin levels were significantly elevated compared with non-climacteric women. Conclusions Altogether, these data support the hypothesis that leptin is elevated, at least partially, as a function of age and climacterium and is not necessarily correlated with metabolic dysfunction and systemic inflammation. Further studies are needed to evaluate the impact of higher leptin levels on postmenopausal women. Arch Endocrinol Metab. 2020;64(3):276-81